可待因-话题@MedSci - 梅斯（MedSci）

#可待因#

7篇内容 | 1178人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1407212, encodeId=51b1140e21239, content=<a href='/topic/show?id=1bdc3845181' target=_blank style='color:#2F92EE;'>#可待因#</a>, objectTitle=.JAMA Netw Open：盐酸羟考酮(强阿片类药物)与对乙酰氨基酚和可待因(轻度阿片类药物)联合应用治疗骨折手术后亚急性疼痛的疗效比较, objectType=article, longId=301610, objectId=eccb301610a4, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=eccb301610a4, replyNumber=0, likeNumber=76, createdTime=2022-03-26, rootId=0, userName=guojianrong, userId=20462610492, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=eccb301610a4, moduleTitle=.JAMA Netw Open：盐酸羟考酮(强阿片类药物)与对乙酰氨基酚和可待因(轻度阿片类药物)联合应用治疗骨折手术后亚急性疼痛的疗效比较, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=eccb301610a4)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1407211, encodeId=287b140e211d0, content=<a href='/topic/show?id=1bdc3845181' target=_blank style='color:#2F92EE;'>#可待因#</a>, objectTitle=国家药监局：18岁以下禁用含可待因感冒药, objectType=article, longId=148375, objectId=67c51483e56f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=67c51483e56f, replyNumber=0, likeNumber=92, createdTime=2018-09-08, rootId=0, userName=guojianrong, userId=20462610492, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=67c51483e56f, moduleTitle=国家药监局：18岁以下禁用含可待因感冒药, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=67c51483e56f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1407210, encodeId=9306140e21099, content=<a href='/topic/show?id=1bdc3845181' target=_blank style='color:#2F92EE;'>#可待因#</a>, objectTitle=含可待因感冒药18岁以下禁用！总局发文了, objectType=article, longId=141844, objectId=a8fa14184464, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a8fa14184464, replyNumber=0, likeNumber=74, createdTime=2018-06-30, rootId=0, userName=guojianrong, userId=20462610492, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a8fa14184464, moduleTitle=含可待因感冒药18岁以下禁用！总局发文了, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=a8fa14184464)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1407209, encodeId=a9d8140e209f9, content=<a href='/topic/show?id=1bdc3845181' target=_blank style='color:#2F92EE;'>#可待因#</a>, objectTitle=Drug Safety：安全相关规定对儿童可待因使用的影响, objectType=article, longId=107914, objectId=cdf910e9146d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=cdf910e9146d, replyNumber=0, likeNumber=66, createdTime=2017-08-08, rootId=0, userName=guojianrong, userId=20462610492, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=cdf910e9146d, moduleTitle=Drug Safety：安全相关规定对儿童可待因使用的影响, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=cdf910e9146d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1407208, encodeId=f352140e2082d, content=<a href='/topic/show?id=1bdc3845181' target=_blank style='color:#2F92EE;'>#可待因#</a>, objectTitle=PEDIATRICS：是时候该对可待因说“不”了！, objectType=article, longId=78107, objectId=beefe810798, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=beefe810798, replyNumber=0, likeNumber=65, createdTime=2016-09-23, rootId=0, userName=guojianrong, userId=20462610492, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=beefe810798, moduleTitle=PEDIATRICS：是时候该对可待因说“不”了！, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=beefe810798)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1407207, encodeId=d73c140e20778, content=<a href='/topic/show?id=1bdc3845181' target=_blank style='color:#2F92EE;'>#可待因#</a>, objectTitle=FDA重新审查可待因治疗18岁以下儿童咳嗽的安全性, objectType=article, longId=52839, objectId=a6785283909, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a6785283909, replyNumber=0, likeNumber=75, createdTime=2015-07-05, rootId=0, userName=guojianrong, userId=20462610492, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a6785283909, moduleTitle=FDA重新审查可待因治疗18岁以下儿童咳嗽的安全性, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=a6785283909)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1407206, encodeId=883d140e20676, content=<a href='/topic/show?id=1bdc3845181' target=_blank style='color:#2F92EE;'>#可待因#</a>, objectTitle=欧洲限制可待因用于儿童疼痛, objectType=article, longId=23156, objectId=2dfe231561a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2dfe231561a, replyNumber=0, likeNumber=70, createdTime=2013-08-21, rootId=0, userName=guojianrong, userId=20462610492, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2dfe231561a, moduleTitle=欧洲限制可待因用于儿童疼痛, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=2dfe231561a)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

可待因

2020-05-29

guojianrong (审核中...)

前往app查看评论内容

#可待因#

.JAMA Netw Open：盐酸羟考酮(强阿片类药物)与对乙酰氨基酚和可待因(轻度阿片类药物)联合应用治疗骨折手术后亚急性疼痛的疗效比较

2022-03-26

guojianrong (审核中...)

前往app查看评论内容

#可待因#

国家药监局：18岁以下禁用含可待因感冒药

2018-09-08

guojianrong (审核中...)

前往app查看评论内容

#可待因#

含可待因感冒药18岁以下禁用！总局发文了

2018-06-30

guojianrong (审核中...)

前往app查看评论内容

#可待因#

Drug Safety：安全相关规定对儿童可待因使用的影响

2017-08-08

guojianrong (审核中...)

前往app查看评论内容

#可待因#

PEDIATRICS：是时候该对可待因说“不”了！

2016-09-23

guojianrong (审核中...)

前往app查看评论内容

#可待因#

FDA重新审查可待因治疗18岁以下儿童咳嗽的安全性

2015-07-05

guojianrong (审核中...)

前往app查看评论内容

#可待因#

欧洲限制可待因用于儿童疼痛

2013-08-21

科室
- - 订阅+
  - 更多科室
工具
服务